ストックスクリーナーアプリを入手
223.32
0.29%
-0.66
前日終値:
$223.98
開ける：
$223.685
24時間の取引高:
5.40M
Relative Volume:
0.92
時価総額：
$394.69B
収益：
$59.64B
当期純損益:
$2.36B
株価収益率:
168.51
EPS:
1.3253
ネットキャッシュフロー:
$19.68B
1週間 パフォーマンス:
-1.22%
1か月 パフォーマンス:
-4.25%
6か月 パフォーマンス:
+16.06%
1年 パフォーマンス:
+28.95%
1日の値動き範囲:
$221.10
$223.82
1週間の範囲:
$220.23
$226.12
52週間の値動き範囲:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
ABBV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
223.32 | 395.86B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
LLY
Lilly Eli Co
|
1,027.51 | 903.41B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
211.58 | 505.98B | 92.15B | 25.12B | 20.46B | 10.36 |
|
NVS
Novartis Ag Adr
|
132.57 | 253.97B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
100.30 | 245.75B | 63.90B | 19.05B | 13.05B | 7.5596 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-11-04 | ダウングレード | DZ Bank | Buy → Hold |
| 2025-10-14 | ダウングレード | Erste Group | Buy → Hold |
| 2025-10-01 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-09-17 | アップグレード | Berenberg | Hold → Buy |
| 2025-08-12 | 再開されました | Piper Sandler | Overweight |
| 2025-08-07 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-12-05 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-04 | アップグレード | Argus | Hold → Buy |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-06-05 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-05-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-01-29 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-12-11 | アップグレード | Goldman | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-10-30 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 再開されました | UBS | Neutral |
| 2023-09-29 | 開始されました | Raymond James | Outperform |
| 2023-07-25 | 開始されました | William Blair | Mkt Perform |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-04-05 | ダウングレード | Argus | Buy → Hold |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2023-02-22 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | アップグレード | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-11-08 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-08-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Underperform |
| 2022-05-06 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2022-02-28 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-03 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-03 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-03 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-03 | 繰り返されました | Goldman | Neutral |
| 2022-01-13 | 開始されました | Redburn | Buy |
| 2022-01-12 | 繰り返されました | BMO Capital Markets | Outperform |
| 2021-12-09 | 再開されました | Wells Fargo | Overweight |
| 2021-11-23 | アップグレード | Societe Generale | Hold → Buy |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-06-23 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | アップグレード | Argus | Hold → Buy |
| 2020-05-18 | 再開されました | BofA/Merrill | Neutral |
| 2020-05-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 再開されました | Morgan Stanley | Overweight |
| 2020-04-20 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | ダウングレード | Societe Generale | Buy → Hold |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-02-06 | 開始されました | Mizuho | Buy |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 繰り返されました | Cowen | Outperform |
| 2019-09-26 | アップグレード | Citigroup | Neutral → Buy |
| 2019-08-20 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-04-29 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
すべてを表示
Abbvie Inc (ABBV) 最新ニュース
North Dallas Bank & Trust Co. Invests $1.68 Million in AbbVie Inc. $ABBV - MarketBeat
Public Sector Pension Investment Board Has $165.77 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever. - The Motley Fool
Advisory Services Network LLC Grows Position in AbbVie Inc. $ABBV - MarketBeat
Assessing AbbVie (ABBV) Valuation After HSBC Upgrade, Strong Earnings, and Dividend Hike - Yahoo Finance UK
My Top 3 Healthcare Stocks to Buy in 2026 - Finviz
AbbVie Inc. $ABBV Shares Acquired by Curi Capital LLC - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Engineers Gate Manager LP - MarketBeat
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 59,257 Shares of AbbVie Inc. $ABBV - MarketBeat
Bridgeway Capital Management LLC Purchases Shares of 110,140 AbbVie Inc. $ABBV - MarketBeat
Bellevue Group AG Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
Benjamin Edwards Inc. Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Ameriprise Financial Inc. Sells 3,127,890 Shares of AbbVie Inc. $ABBV - MarketBeat
Adage Capital Partners GP L.L.C. Lowers Position in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie stock too cheap to ignore at today's price? - MSN
AbbVie Stock (ABBV) After-Hours Update: What Happened on Dec. 12, 2025—and What to Watch Before the Next Market Open - ts2.tech
ABBV Stock News: Lenz Therapeutics Faces Setback with FDA Report - GuruFocus
Morgan Stanley Maintains Overweight Rating on ABBV, Raises Price Target to $269 | ABBV Stock News - GuruFocus
Morgan Stanley Adjusts Price Target on AbbVie to $269 From $261, Maintains Overweight Rating - marketscreener.com
AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock - Finviz
Treasurer of the State of North Carolina Sells 27,645 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Quantinno Capital Management LP - MarketBeat
Hamilton Capital LLC Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Peapack Gladstone Financial Corp Acquires 20,164 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Nebula Research & Development LLC - MarketBeat
Canada Pension Plan Investment Board Has $466.58 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Diversify Advisory Services LLC Purchases 10,883 Shares of AbbVie Inc. $ABBV - MarketBeat
Alliancebernstein L.P. Increases Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025) - ts2.tech
Hot Picks: Large-cap health care stocks to watch for dividend growth - BNN Bloomberg
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts - ts2.tech
Is AbbVie Stock Too Cheap to Ignore at Today's Price? - sharewise.com
Botox maker quietly launches plan to fend off rivals - Yahoo Finance
'This is a great opportunity to get, what we call, a dividend growing stock': Nesbitt on Abbvie Inc. - BNN Bloomberg
$73 Billion Non-Opioid Therapeutics Industry Assessment, 2032 Featuring AbbVie, GlaxoSmithKline, Acorda Therapeutics, Allay Therapeutics, Alnylam Pharmaceuticals and Other Key Players - Yahoo Finance
Glenview Trust co Has $78.24 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth - The Globe and Mail
The Manufacturers Life Insurance Company Raises Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Scotiabank Sticks to Their Buy Rating for AbbVie (ABBV) - The Globe and Mail
CIBC Asset Management Inc Has $59.11 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265 - Finviz
AbbVie: Unique Mix Of Growth And Value (NYSE:ABBV) - Seeking Alpha
ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL - Yahoo Finance
AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma - MSN
AbbVie upgraded, Biogen downgraded at HSBC (BIIB:NASDAQ) - Seeking Alpha
Crohn’s Disease Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | AbbVie, Merck, Eli Lilly and Company, RedHill Biopharma, Bristol Myers Squibb, Dr. Falk Pharma GmbH - Barchart.com
Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More - Yahoo Finance
AbbVie Stock (ABBV) Opinions on Analyst Upgrade and Pipeline Developments - Quiver Quantitative
Intact Investment Management Inc. Sells 8,200 Shares of AbbVie Inc. $ABBV - MarketBeat
Here Are Wednesday's Top Wall Street Analyst Research Calls: AbbVie, Amazon.com, Biogen, EchoStar, Ferrari, GE Vernova, PepsiCo, Take-Two Interactive, and More - 24/7 Wall St.
NewEdge Advisors LLC Has $103.13 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Abbvie Inc (ABBV) 財務データ
収益
当期純利益
現金流量
EPS
0.75%
0.22%
大文字化:
|
ボリューム (24 時間):